Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Ingredients

Read more breaking news


News in brief

URL acquires PharmaPro assets


URL Pharma has acquired a 19,000 sq ft facility equipped for development and manufacture of modified release products from PharmPro.

The facility includes fluid bed technology, which is used in the water and solvent coating processes that are needed in the development and manufacture of modified release products.

Furthermore, the acquisition includes DuraGran. This is a proprietary technology platform enables the production of uniform, small granules, which are also used in modified release products.

URL will also acquire the services of 17 former PharmPro employees that have critical engineering expertise. These employees, infrastructure and technology have been acquired to improve URL’s in-house capabilities.

Key Industry Events


Access all events listing

Our events, Events from partners...


Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry
Need help to bring insoluble APIs to the market?
Dow Pharma & Food Solutions